Psychiatric genetics: Understanding its scope and limitations for Indian families
The article explores what psychiatric genetics can offer Indian families, emphasizing that while it can reduce blame and acknowledge biological factors in mental illness, it cannot determine destiny. It highlights that genes indicate vulnerability, not fate, and that polygenic risk scores developed from European ancestry databases may not be accurate for India's diverse population. The author stresses the importance of protecting privacy and focusing on early intervention and support rather than relying solely on genetic labels, advocating for proper exercise of psychiatric genomics involving diverse populations and ethical considerations to avoid misuse or commercialization.
Key Points
- Psychiatric genetics can help reduce blame and acknowledge biological contributions to mental illness, but it does not determine an individual's destiny.
- Polygenic risk scores, often developed from European populations, may not accurately reflect the genetic diversity within India.
- The genome-wide association study (GWAS) identifies common genetic variants associated with conditions, but no single gene determines complex psychiatric disorders.
- Ethical considerations, privacy protection, and community involvement are crucial in the application of psychiatric genomics.
- Focus should be on early warning signs, timely care, and support rather than solely on genetic labels.
Exam Facts
- Genome-wide association study (GWAS) is a key research tool in psychiatric genetics.
- The GenomIndia project generated whole-genome data from 10,000 healthy, unrelated Indians across 83 population groups.
- A 2022 schizophrenia study identified associations at 287 genomic regions.
- A 2021 bipolar disorder study identified 64 associated regions.
Read it. Retain it. Recall it.
Get spaced-repetition flashcards, daily quizzes and offline access — free on Android.